KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lam Research (LRCX) EBT: 2009-2025

Historic EBT for Lam Research (LRCX) over the last 17 years, with FY2025 value amounting to $6.0 billion.

  • Lam Research's EBT rose 4364.47% to $1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 billion, marking a year-over-year increase of 4092.02%. This contributed to the annual value of $6.0 billion for FY2025, which is 3664.74% up from last year.
  • According to the latest figures from FY2025, Lam Research's EBT is $6.0 billion, which was up 3664.74% from $4.4 billion recorded in FY2024.
  • Lam Research's 5-year EBT high stood at $6.0 billion for FY2025, and its period low was $4.4 billion during FY2024.
  • Its 5-year average for EBT is $5.0 billion, with a median of $5.1 billion in 2023.
  • As far as peak fluctuations go, Lam Research's EBT surged by 6974.14% in 2021, and later crashed by 1465.96% in 2024.
  • Annual analysis of 5 years shows Lam Research's EBT stood at $4.4 billion in 2021, then increased by 18.81% to $5.2 billion in 2022, then dropped by 1.62% to $5.1 billion in 2023, then decreased by 14.66% to $4.4 billion in 2024, then surged by 36.65% to $6.0 billion in 2025.
  • Its EBT was $6.0 billion in FY2025, compared to $4.4 billion in FY2024 and $5.1 billion in FY2023.